Compare
SPAR Group, Inc. vs Bridger Aerospace Group Holdings, Inc. vs OptimizeRx Corp vs Janel Corp
| Latest fiscal year | SPAR Group, Inc. SGRP | Bridger Aerospace Group Holdings, Inc. BAER | OptimizeRx Corp OPRX | Janel Corp JANL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $136.10M | $122.83M | $109.43M | $207.44M |
| Revenue growth (YoY) | -16.8% | +24.6% | +18.8% | +13.2% |
| Gross margin | 15.9% | 42.1% | 67.3% | 31.3% |
| Operating margin | -12.4% | n/a | 10.7% | 3.1% |
| Net margin | -18.1% | 3.4% | 4.7% | 2.7% |
| Net income | -$24.63M | $4.14M | $5.13M | $5.66M |
| EPS (Diluted) | -$1.04 | -$0.42 | $0.27 | $4.17 |
| Operating cash flow | -$18.44M | $16.73M | $18.71M | $43.07M |
| Free cash flow | -$21.42M | -$64.21M | $18.66M | n/a |
| Cash & equivalents | $3.26M | $31.38M | $23.36M | n/a |
| Total assets | $44.06M | $330.31M | $176.92M | $170.75M |
| Total liabilities | $43.44M | $265.64M | $48.62M | $144.95M |
| Shareholders' equity | $622.0K | -$342.59M | $128.29M | $25.80M |
| Return on year-end equity | n/m | n/a | 4.0% | 21.9% |
| Shares outstanding | 24.13M | 55.89M | 18.76M | 1.19M |
Revenue, most recent five fiscal years
| Fiscal year | SPAR Group, Inc. | Bridger Aerospace Group Holdings, Inc. | OptimizeRx Corp | Janel Corp |
|---|---|---|---|---|
| Latest | $136.10M Ended 2025-12-31 | $122.83M Ended 2025-12-31 | $109.43M Ended 2025-12-31 | $207.44M Ended 2025-09-30 |
| 1 year earlier | $163.63M Ended 2024-12-31 | $98.61M Ended 2024-12-31 | $92.13M Ended 2024-12-31 | $183.18M Ended 2024-09-30 |
| 2 years earlier | $187.87M Ended 2023-12-31 | $66.71M Ended 2023-12-31 | $71.52M Ended 2023-12-31 | $186.45M Ended 2023-09-30 |
| 3 years earlier | $261.27M Ended 2022-12-31 | $46.39M Ended 2022-12-31 | $62.45M Ended 2022-12-31 | $316.86M Ended 2022-09-30 |
| 4 years earlier | $255.72M Ended 2021-12-31 | n/a | $61.29M Ended 2021-12-31 | $146.42M Ended 2021-09-30 |